Renaissance Technologies
ANVS icon

Renaissance Technologies’s Annovis Bio ANVS Stock Holding History

Renaissance Technologies’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$775K Buy
+347,600
New +$953K ﹤0.01% 2399
2025
Q2 		– Sell
-21,800
Closed -$32.7K – 3537
2025
Q1 		$32.7K Buy
+21,800
New +$66.7K ﹤0.01% 3333
2022
Q3 		– Sell
-16,700
Closed -$189K – 4002
2022
Q2 		$189K Sell
16,700
-6,497
-28% -$71K ﹤0.01% 3669
2022
Q1 		$310K Buy
23,197
+12,697
+121% +$183K ﹤0.01% 3459
2021
Q4 		$185K Buy
+10,500
New +$271K ﹤0.01% 3537
2021
Q2 		– Sell
-19,900
Closed -$555K – 3430
2021
Q1 		$555K Buy
+19,900
New +$426K ﹤0.01% 2871
2020
Q4 		– Sell
-20,615
Closed -$99K – 3362
2020
Q3 		$99K Buy
+20,615
New +$110K ﹤0.01% 3215

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies's ANVS Position: Q1 2026 in Review

Renaissance Technologies opened a new position in Annovis Bio (ANVS) in Q1 2026: 347,600 shares worth $775K. The stake represents ﹤0.01% of the portfolio and ranks #2399 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in ANVS as recently as Q1 2025.

Renaissance Technologies first reported a position in ANVS in Q3 2020 and has held it in 7 quarters since. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Renaissance Technologies held 347,600 shares of Annovis Bio worth $775K as of Q1 2026.
  • Annovis Bio was a new Renaissance Technologies position in Q1 2026.
  • Annovis Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2399 holding.
  • Renaissance Technologies first reported a position in Annovis Bio in Q3 2020 and has held it in 7 quarters since.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.